Tuberculosis management by private practitioners in Mumbai, India: Has anything changed in two decades?

PLoS ONE

Volumn 5, Issue 8, 2010, Pages

  Udwadia, Zarir F ^a   Pinto, Lancelot M ^a   Uplekar, Mukund W ^b  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; LEVOFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ALTERNATIVE MEDICINE; ARTICLE; GENERAL PRACTITIONER; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; MEDICAL EDUCATION; MULTIDRUG RESISTANT TUBERCULOSIS; PRESCRIPTION; PRIVATE PRACTICE; QUESTIONNAIRE; TUBERCULOSIS; EDUCATION; HEALTH CARE PLANNING; HISTORY; INDIA; INTERNATIONAL COOPERATION; STATISTICS;

COMPLEMENTARY THERAPIES; DRUG PRESCRIPTIONS; HEALTH PLANNING GUIDELINES; HISTORY, 21ST CENTURY; HUMANS; INDIA; INTERNATIONALITY; PRIVATE PRACTICE; TUBERCULOSIS;

EID: 77957817011     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012023     Document Type: Article

References (22)

1. Uplekar MW, Shepard DS (1991) Treatment of tuberculosis by private general practitioners in India. Tubercle 72: 284-290.
2. Central TB Division. Directorate General of Health Services. Ministry of Health and Family welfare (2008) Available at http://www.tbcindia.org/pdfs/ New%20Schemes%20NGO-PP%20140808.pdf Accessed 27 December 2009.
3. Uplekar M, Pathania V, Raviglione M (2001) Private practitioners and public health: weak links in tuberculosis control. Lancet 358: 912-916.
4. World Health Organization (2006) Engaging all care providers in tuberculosis care and control: guidance on implementing public-private mix approaches WHO, Geneva.
5. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India (2009) TB India 2009 RNTCP Status report. Available at http://www.tbcindia.org/pdfs/TB%20India%202009.pdf Accessed 1 February 2010.
6. World Health Organization (2009) Global tuberculosis control: surveillance, planning, financing. WHO report 2009. Geneva, World Health Organization (WHO/HTM/TB/2009.).
7. Rodrigues C, Shenai S, Sadani M, Thakkar P, Sodha A, et al. (2006) Multidrugresistant tuberculosis in Mumbai: it's only getting worse. Int J Tuberc Lung Dis 10: 1421-1422.
8. Almeida D, Rodrigues C, Udwadia ZF, Lalvani A, Gothi GD, et al. (2003) Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for prevention. Clin Infect Dis 36: e152-154.
9. World Health Organization. Treatment of Tuberculosis: guidelines for national programmes. WHO, Geneva. (WHO/CDS/TB/2003.313).
10. Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC (2006) International standards for tuberculosis care. Lancet Infect Dis 6: 710-725.
11. Uplekar M, Juvekar S, Morankar S, Rangan S, Nunn P (1998) Tuberculosis patients and practitioners in private clinics in India. Int J Tuberc Lung Dis 2: 324-329.
12. International Institute for Population Sciences (IIPS) and Macro International 2007. National Family Health Survey (NFHS-3), 2005-06: India: Volume I.
13. Kelkar-Khambete A, Kielmann K, Pawar S, Porter J, Inamdar V, et al. (2008) India's Revised National Tuberculosis Control Programme: looking beyond detection and cure. Int J Tuberc Lung Dis 12: 87-92.
14. Pinto LM, Udwadia ZF (2010) Private patient perceptions about a public programme; what do private Indian tuberculosis patients really feel about directly observed treatment? BMC Public Health 10: 357.
15. Global Alliance for TB drug development (2007) Pathway to patients: charting the dynamics of the global TB drug market. TB Alliance, New York.
16. Chugh S (2008) IMA GFATM RNTCP PPM: gearing up to face ground realities. J Indian Med Assoc 106: 596-599.
17. Dewan PK, Lal SS, Lonnroth K, Wares F, Uplekar M, et al. (2006) Improving tuberculosis control through public-private collaboration in India: literature review. BMJ 332: 574-578.
18. Pantoja A, Lonnroth K, Lal SS, Chauhan LS, Uplekar M, et al. (2009) Economic evaluation of public-private mix for tuberculosis care and control, India. Part II. Cost and cost-effectiveness. Int J Tuberc Lung Dis 13: 705-712.
19. World Health Organization. Anti-tuberculosis drug resistance in the world, Fourth Global Report, WHO, Geneva (WHO/HTM/TB/2008.394). Available at http://www.who.int/tb/publications/2008/drs_report4_26feb08.pdf.
20. D'Souza D T, Mistry NF, Vira TS, Dholakia Y, Hoffner S, et al. (2009) High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India. BMC Public Health 9: 211.
21. Jain S RC, Mehta A, et al. High prevalence of XDR-TB from a tertiary hospital in India. American Thoracic Society 2007 International Conference; San Francisco, CA, USA; May 18-23, 2007 Abstract A510.
22. Agrawal D, Udwadia ZF, Rodriguez C, Mehta A (2009) Increasing incidence of fluoroquinolone-resistant Mycobacterium tuberculosis in Mumbai, India. Int J Tuberc Lung Dis 13: 79-83.